These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31341157)

  • 1. Investigation of Insulin-Like Growth Factor-1 (IGF-1), P53, and Wilms' Tumor 1 (WT1) Expression Levels in the Colon Polyp Subtypes in Colon Cancer.
    Aslan A; Erdem H; Celik MA; Sahin A; Cankaya S
    Med Sci Monit; 2019 Jul; 25():5510-5517. PubMed ID: 31341157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of Wilms Tumor Gene (WT1) and p53 expression in curettage specimens of patients with endometrial carcinomas.
    Matalka I; Obeidat B; Mohtaseb A; Awamleh A
    Pathol Res Pract; 2013 Jan; 209(1):19-23. PubMed ID: 23207289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilms Tumor Gene (WT1) and p53 expression in endometrial carcinomas: a study of 130 cases using a tissue microarray.
    Dupont J; Wang X; Marshall DS; Leitao M; Hedvat CV; Hummer A; Thaler H; O'Reilly RJ; Soslow RA
    Gynecol Oncol; 2004 Aug; 94(2):449-55. PubMed ID: 15297187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
    Sarfstein R; Werner H
    J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation.
    Idelman G; Glaser T; Roberts CT; Werner H
    J Biol Chem; 2003 Jan; 278(5):3474-82. PubMed ID: 12444079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
    Tajinda K; Carroll J; Roberts CT
    Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer.
    Tuna M; Itamochi H
    Tumori; 2013; 99(6):715-22. PubMed ID: 24503796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance and prognostic value of Wilms' tumor gene expression in colorectal cancer.
    Miyata Y; Kumagai K; Nagaoka T; Kitaura K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
    Cancer Biomark; 2015; 15(6):789-97. PubMed ID: 26406403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon.
    Oh K; Redston M; Odze RD
    Hum Pathol; 2005 Jan; 36(1):101-11. PubMed ID: 15712188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Proposed Kinetic Model for the Diagnostic and Prognostic Value of WT1 and p53 in Acute Myeloid Leukemia.
    Bani-Ahmad MA; Al-Sweedan SA; Al-Asseiri MA; Alkhatib AJ
    Clin Lab; 2018 Mar; 64(3):357-363. PubMed ID: 29739109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.
    Acs G; Pasha T; Zhang PJ
    Int J Gynecol Pathol; 2004 Apr; 23(2):110-8. PubMed ID: 15084838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of WT1 and p53 in serous and endometrioid carcinomas of the endometrium.
    Egan JA; Ionescu MC; Eapen E; Jones JG; Marshall DS
    Int J Gynecol Pathol; 2004 Apr; 23(2):119-22. PubMed ID: 15084839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
    J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.
    Werner H; Re GG; Drummond IA; Sukhatme VP; Rauscher FJ; Sens DA; Garvin AJ; LeRoith D; Roberts CT
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5828-32. PubMed ID: 8390684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of IGF-1Ec with increasing colonic polyp dysplasia and colorectal cancer.
    Alagaratnam S; Loizidou M; Yang SY; Fuller B; Ramesh B
    J Cancer Res Clin Oncol; 2020 Nov; 146(11):2861-2870. PubMed ID: 32772171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Wilms' tumor gene expression in tumor tissues predicts poor prognosis in patients with non-small-cell lung cancer.
    Hayashi S; Oji Y; Kanai Y; Teramoto T; Kitaichi M; Kawaguchi T; Okada M; Sugiyama H; Matsumura A
    Cancer Invest; 2012 Feb; 30(2):165-71. PubMed ID: 22148937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The WT1 Wilms' tumor suppressor gene: a novel target for insulin-like growth factor-I action.
    Bentov I; LeRoith D; Werner H
    Endocrinology; 2003 Oct; 144(10):4276-9. PubMed ID: 12960088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms' tumor gene 1 enhances nutlin-3-induced apoptosis.
    Lee SY; Choe YJ; Park JY; Lee SS; Kim YH; Shin SJ; Chung YJ; Kim HS
    Oncol Rep; 2014 Jan; 31(1):131-6. PubMed ID: 24190574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer.
    Han L; Zhang GF; Cheng YH; Zhao QC
    Jpn J Clin Oncol; 2016 Dec; 46(12):1127-1134. PubMed ID: 27737962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.